MFS
RNAC icon

Mirabella Financial Services’s Cartesian Therapeutics RNAC Stock Holding History

Mirabella Financial Services’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,847
Closed -$4.03M – 631
2023
Q1 		$4.03M Buy
4,847
+3,684
+317% +$173K 0.61% 49
2022
Q4 		$39.4K Buy
+1,163
New +$49.5K ﹤0.01% 369
2022
Q2 		– Sell
-2,233
Closed -$82K – 679
2022
Q1 		$82K Buy
+2,233
New +$140K 0.01% 445

Other funds holding RNAC

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirabella Financial Services's RNAC Position: Q2 2023 in Review

Mirabella Financial Services sold out of Cartesian Therapeutics (RNAC) in Q2 2023, closing a stake of 4,847 shares — an estimated $4.03M sold.

Mirabella Financial Services first reported a position in RNAC in Q1 2022 and held it in 3 quarters. The position peaked at $4.03M in Q1 2023. 92 funds tracked by Wall St. Rank hold RNAC as of Q2 2023.

  • Mirabella Financial Services reported no remaining Cartesian Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Mirabella Financial Services sold 4,847 Cartesian Therapeutics shares in Q2 2023, an estimated $4.03M.
  • Mirabella Financial Services first reported a position in Cartesian Therapeutics in Q1 2022 and held it in 3 quarters.
  • Mirabella Financial Services's Cartesian Therapeutics position peaked at $4.03M in Q1 2023.
  • 92 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2023.

Based on Mirabella Financial Services's 13F filing for Q2 2023, filed 7 Aug 2023.